tiprankstipranks
Trending News
More News >
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
Advertisement

GlaxoSmithKline (GSK) Drug Pipeline

Compare
5,120 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Rsvpref3 Oa Vaccine
Respiratory Syncytial Virus Infections
Phase III
Not Yet Recruiting
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
Oct 21, 2025
Sunitinib, Idrx-42
Gastrointestinal Neoplasms
Phase III
Not Yet Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Oct 17, 2025
Efimosfermin Alfa
Non-Alcoholic Fatty Liver Disease
Phase III
Not Yet Recruiting
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Oct 15, 2025
Efimosfermin Alfa
Non-Alcoholic Fatty Liver Disease
Phase III
Not Yet Recruiting
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Oct 15, 2025
Belantamab Mafodotin, Feladilimab
Multiple Myeloma
Phase I/II
Active Not Recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM
Oct 13, 2025
Belantamab Mafodotin, Isatuximab
Multiple Myeloma
Phase I/II
Active Not Recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM
Oct 13, 2025
Comparator 1, Comparator 2, Comparator 3, Flu Mrna (Formulation B1), Flu Mrna (Formulation B3), Flu Mrna(Formulation A)
Influenza, Human
Phase II
Not Yet Recruiting
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
Oct 01, 2025
Gsk3862995b
Bronchiectasis
Phase II
Not Yet Recruiting
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Sep 23, 2025
Depemokimab
Pulmonary Disease, Chronic Obstructive
Phase III
Not Yet Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sep 15, 2025
Bepirovirsen
Hepatitis B
Phase I
Recruiting
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
Sep 10, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does GlaxoSmithKline (GSK) have in its pipeline
      GSK is currently developing the following drugs: Rsvpref3 Oa Vaccine, Sunitinib, Idrx-42, Efimosfermin Alfa. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis